Defence lawyers have hailed the Supreme Court's ruling in Dura Pharmaceuticals for restricting securities fraud litigation. William Sullivan and Tracey DeLange, counsel to Dura, argue that the
ruling is also good for the economy
Unlock this article.
The content you are trying to view is exclusive to our subscribers.